DecompPipeline

DecompPipeline performs reference-free deconvolution preprocessing and feature selection of bulk DNA methylation data to recover cell type–specific methylation signals and latent methylation components (LMCs) from heterogeneous tissues.


Key Features:

  • Preprocessing and Feature Selection: Adjusts for confounders using independent component analysis (ICA) and selects methylation features for downstream deconvolution.
  • Integration with Deconvolution Methods: Interfaces with MeDeCom, RefFreeCellMix, and EDec to enable retrieval of latent methylation components (LMCs) from bulk methylomes.
  • Guided Biological Inference: Supports interpretation and validation of deconvolution results using FactorViz to aid identification of cell-type components.

Scientific Applications:

  • Population-scale methylation analysis: Enables cell type–specific methylation studies across large patient cohorts when single-cell data are unavailable.
  • Tumor heterogeneity and cellular composition: Facilitates dissection of cellular heterogeneity in complex tissues, including identification of tumor and stromal methylation signatures.
  • TCGA lung cancer analyses: Applied to TCGA lung cancer methylomes to identify proportions of stromal cells and tumor-infiltrating immune cells and their associations with clinical parameters.

Methodology:

The protocol comprises three computational stages: data preprocessing (confounder adjustment via ICA and feature selection by DecompPipeline), deconvolution (application of MeDeCom, RefFreeCellMix, and EDec to retrieve LMCs), and biological inference and validation (interpretation using FactorViz).

Topics

Details

Added:
10/13/2020
Last Updated:
11/24/2024

Operations

Data Inputs & Outputs

Deisotoping

Outputs

    Publications

    Scherer M, Nazarov PV, Toth R, Sahay S, Kaoma T, Maurer V, Vedeneev N, Plass C, Lengauer T, Walter J, Lutsik P. Reference-free deconvolution, visualization and interpretation of complex DNA methylation data using DecompPipeline, MeDeCom and FactorViz. Nature Protocols. 2020;15(10):3240-3263. doi:10.1038/s41596-020-0369-6. PMID:32978601.

    PMID: 32978601
    Funding: - Bundesministerium für Bildung und Forschung: 01KU1216A, 031L0101A, 031L0101D - Fonds National de la Recherche Luxembourg: C17/BM/11664971/DEMICS - EC | Horizon 2020 Framework Programme: 733100